Identification of essential genes associated with SARS-CoV-2 infection as potential drug target candidates with machine learning algorithms

被引:0
|
作者
Golnaz Taheri
Mahnaz Habibi
机构
[1] Stockholm University,Department of Computer and Systems Sciences
[2] Science for Life Laboratory,Department of Mathematics, Qazvin Branch
[3] Islamic Azad University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires the fast discovery of effective treatments to fight this worldwide concern. Several genes associated with the SARS-CoV-2, which are essential for its functionality, pathogenesis, and survival, have been identified. These genes, which play crucial roles in SARS-CoV-2 infection, are considered potential therapeutic targets. Developing drugs against these essential genes to inhibit their regular functions could be a good approach for COVID-19 treatment. Artificial intelligence and machine learning methods provide powerful infrastructures for interpreting and understanding the available data and can assist in finding fast explanations and cures. We propose a method to highlight the essential genes that play crucial roles in SARS-CoV-2 pathogenesis. For this purpose, we define eleven informative topological and biological features for the biological and PPI networks constructed on gene sets that correspond to COVID-19. Then, we use three different unsupervised learning algorithms with different approaches to rank the important genes with respect to our defined informative features. Finally, we present a set of 18 important genes related to COVID-19. Materials and implementations are available at: https://github.com/MahnazHabibi/Gene_analysis.
引用
收藏
相关论文
共 50 条
  • [21] Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates
    Ryunosuke Yoshino
    Nobuaki Yasuo
    Masakazu Sekijima
    Scientific Reports, 10
  • [22] Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19
    Rajarshi, Keshav
    Khan, Rajni
    Singh, Mrityunjay K.
    Ranjan, Tushar
    Ray, Sandipan
    Ray, Shashikant
    GENE, 2021, 768
  • [23] Potential Therapeutic Target and Vaccines for SARS-CoV-2
    Hussain, Mohamed A.
    Hassan, Mohamed M.
    Bashir, Bashir Abdrhman
    Gamar, Tarig A.
    Gasmalbari, Elmuaiz
    Mohamed, Ahmed Osman
    Osman, Wadah
    Sherif, Asmaa E.
    Elgaml, Abdelaziz
    Alhaddad, Aisha A.
    Ghazawi, Kholoud F.
    Miski, Samar F.
    Ainousah, Bayan E.
    Andijani, Yusra Saleh
    Ibrahim, Sabrin R. M.
    Mohamed, Gamal A.
    Ashour, Ahmed
    PATHOGENS, 2023, 12 (07):
  • [24] Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2
    Al-Karmalawy, Ahmed A.
    Farid, Mai M.
    Mostafa, Ahmed
    Ragheb, Alia Y.
    H. Mahmoud, Sara
    Shehata, Mahmoud
    Shama, Noura M. Abo
    GabAllah, Mohamed
    Mostafa-Hedeab, Gomaa
    Marzouk, Mona M.
    MOLECULES, 2021, 26 (21):
  • [25] Identification, Characterization and Drug Discovery for Novel Target Sites for SARS-CoV-2 Proteins
    Iyengar, Suhasini
    Barnsley, Kelton
    Hoang Yen Vu
    Herrod, Alyssa
    Bongalonta, Ian
    Scott, Jasmine
    Beuning, Penny
    Ondrechen, Mary Jo
    FASEB JOURNAL, 2021, 35
  • [26] Rapamycin: Drug Repurposing in SARS-CoV-2 Infection
    Patocka, Jiri
    Kuca, Kamil
    Oleksak, Patrik
    Nepovimova, Eugenie
    Valis, Martin
    Novotny, Michal
    Klimova, Blanka
    PHARMACEUTICALS, 2021, 14 (03)
  • [27] SARS-CoV-2 Nucleocapsid Protein Is a Potential Therapeutic Target for Anticoronavirus Drug Discovery
    Royster, Austin
    Ren, Songyang
    Ma, Yutian
    Pintado, Melissa
    Kahng, Eunice
    Rowan, Sean
    Mir, Sheema
    Mir, Mohammad
    MICROBIOLOGY SPECTRUM, 2023, 11 (03):
  • [28] Potential New Placental Pathology Associated with Maternal SARS-CoV-2 Infection
    Ray, Lauren
    Ritter, Jana
    Flannery, Luciana
    Carnes, Marlene DeLeon
    Zukerberg, Lawrence
    Roberts, Drucilla
    Estetter, Lindsey
    LABORATORY INVESTIGATION, 2023, 103 (03) : S972 - S974
  • [29] In Silico Identification of Propolis Compounds Potential as COVID-19 Drug Candidates Against SARS-CoV-2 Spike Protein
    Sahlan, Muhamad
    Dewi, Lia Kusuma
    Pratami, Diah Kartika
    Lischer, Kenny
    Hermansyah, Heri
    INTERNATIONAL JOURNAL OF TECHNOLOGY, 2023, 14 (02) : 387 - 398
  • [30] Integrin activation is an essential component of SARS-CoV-2 infection
    Simons, Peter
    Rinaldi, Derek A.
    Bondu, Virginie
    Kell, Alison M.
    Bradfute, Steven
    Lidke, Diane
    Buranda, Tione
    SCIENTIFIC REPORTS, 2021, 11 (01)